Orbital metastasis of multiple myeloma: case report.
Multiple myeloma (MM) is a malignancy characterized by abnormal plasma cell proliferation and is generally confined to the bone marrow. However, 3% of cases may develop extramedullary involvement, defined as the formation of solid plasmacytomas outside the bone marrow. (1) Extramedullary involvement usually occurs in the upper skeletal system, but rarely orbital manifestations are observed. (2,3,4) The most common ocular signs and symptoms in orbital involvement are proptosis, redness, pain, diplopia, and impaired vision; proptosis is an indicator of metastasis and recurrence. This report presents a case of orbital involvement observed during follow-up of an MM patient in remission.
A 68-year-old female patient presented to our clinic with bilateral progressive vision loss for the previous 2 years. The patient had been diagnosed with MM 5 years earlier but was in remission at time of presentation and had no other systemic diseases in her medical history. On ophthalmologic examination her best corrected visual acuity (BCVA) was 3/10 in the right eye and 2/10 in the left eye. Anterior segment examination revealed cataract in both eyes. Posterior segment examination was normal. The patient underwent uncomplicated cataract surgery under local anesthesia on the left eye first, followed by the right eye a month later. She experienced no problems postoperatively and her uncorrected visual acuity was 7/10 in both eyes at the follow-up examination. No pathologies were observed during anterior or posterior examinations. The patient presented to our clinic about 15 days after her final follow-up appointment with complaints of pain, redness and low vision in her right eye. Her BCVA was 3/10 and 8/10 in the right and left eye, respectively. Proptosis was evident and eye movements were restricted in all directions in her right eye. On anterior segment examination of the right eye, subconjunctival hemorrhage and hyperemia were observed (Figure 1). Posterior segment examination of the right eye revealed optic disc edema and widespread choroidal folds (Figure 2). These clinical signs combined with the patient's history of MM suggested orbital metastasis, and urgent radiologic imaging was ordered. Magnetic resonance imaging revealed two mass lesions in the right orbital space behind the globe. In contrast-enhanced images the lesions showed homogeneous enhancement, and invasion of the extraocular muscles, disruption of globe shape and optic nerve compression were observed. In addition, mass lesions showing heterogeneous enhancement were present in both temporal fossa (Figure 3). The diagnosis was confirmed using a biopsy obtained from the temporal fossa lesion (Figure 4), and the patient was referred to the radiation oncology department for consultation. Palliative radiotherapy (RT) was recommended.
Ocular findings in MM may arise from systemic effects of the disease (increased blood viscosity) or infiltration of plasma cells into ocular tissues. (4) These ocular findings may include crystalline corneal deposits, exudative macular detachment, ciliary body cysts and retinal hemorrhage. Though rare, orbital involvement may be an extramedullary manifestation. The most common clinical sign of orbital involvement in MM is unilateral proptosis, while hyperemia, pain, diplopia and low vision occur less often. (5) There are also reports of bilateral proptosis in some cases. (5) Similarly, our case presented with proptosis, subconjunctival hemorrhage, pain and vision loss. Her ocular motility limitation, optic disc edema and choroidal folds resulted from a metastatic mass located posterior to the globe which was invading the extraocular muscles and applying pressure to both the globe and the optic nerve. All of these findings have been observed in similar cases of orbital involvement. (1,2,6,7,8)
Approximately 9% of orbital tumors in adults are metastases, and orbital metastases usually originate from lung and breast cancers. (9) There have also been reports of kidney, pancreas, prostate and gastric cancers forming orbital metastases. (10,11) The presence of metastasis in MM indicates a poor prognosis. Orbital metastases in particular have worse survival rates compared to other extramedullary plasmacytomas. (6) Mean expected survival for patients with recurrence is 12 months in the absence of systemic involvement, less in cases with systemic involvement. Of all malignancies occurring during remission, approximately one in three is orbital.
RT is an effective palliative therapy for MM patients, especially those with symptomatic local manifestations. (12,13) Palliative RT is indicated for deficits related to pain, bone involvement, spinal cord compression, root compression and cranial nerve involvement. We recommended RT in this case due to the pain that accompanied the orbital involvement.
Proptosis has an important role in the differential diagnosis of malignancies. In cases like this, imaging should be done immediately and the differential diagnosis should be considered. It should be kept in mind that proptosis can be the first sign of relapse in a patient previously diagnosed with MM.
Informed Consent: It was taken. Peer-review: Externally and internally peer-reviewed.
Surgical and Medical Practices: Mustafa Vatansever, Fatma Merve Bozkurt, Erdem Dinc, Eda Bengi Yilmaz, Erdinc Nayir, Ayse Ayca Sari, Ozlem Yildirim, Tuba Kara, Concept: Mustafa Vatansever, Fatma Merve Bozkurt, Erdem Dinc, Eda Bengi Yilmaz, Erdinc Nayir, Ayse Ayca Sari, Ozlem Yildirim, Tuba Kara, Design: Mustafa Vatansever, Fatma Merve Bozkurt, Erdem Dinc, Eda Bengi Yilmaz, Erdinc Nayir, Ayse Ayca Sari, Ozlem Yildirim, Tuba Kara, Data Collection or Processing: Mustafa Vatansever, Fatma Merve Bozkurt, Erdem Dinc, Eda Bengi Yilmaz, Erdinc Nayir, Ayse Ayca Sari, Ozlem Yildirim, Tuba Kara, Analysis or Interpretation: Mustafa Vatansever, Fatma Merve Bozkurt, Erdem Dinc, Eda Bengi Yilmaz, Erdinc Nayir, Ayse Ayca Sari, Ozlem Yildirim, Tuba Kara, Literature Search: Mustafa Vatansever, Fatma Merve Bozkurt, Erdem Dinc, Eda Bengi Yilmaz, Erdinc Nayir, Ayse Ayca Sari, Ozlem Yildirim, Tuba Kara, Writing: Mustafa Vatansever, Fatma Merve Bozkurt, Erdem Dinc, Eda Bengi Yilmaz, Erdinc Nayir, Ayse Ayca Sari, Ozlem Yildirim, Tuba Kara.
Conflict of Interest: No conflict of interest was declared by the authors.
Financial Disclosure: The authors declared that this study received no financial support.
(1.) Adkins JW Shields JA, Shields CL, Eagle RC Jr, Flanagan JC, Campanella PC. Plasmacytoma of the eye and orbit. Int Ophthalmol. 1996;20:339-343.
(2.) Chim CS, Ng I, Trendell-Smith NJ, Liang R. Primary extramedullary plasmacytoma of the lacrimal gland. Leukemia Lymphoma. 2003;42:831-834.
(3.) Rodman HI, Font RL. Orbital involvement in multiple myeloma. Review of the literature and report of three cases. Arch Ophthalmol. 1972;87:30-35.
(4.) Knapp AJ, Gartner S, Henkind P Multiple myeloma and its ocular manifestations. Surv Ophthalmol. 1987;5:343-351.
(5.) Malik A, Narang S, Handa U, Sood S. Multiple myeloma presenting as bilateral orbital proptosis. Indian J Ophthalmol. 2009;57:393-395.
(6.) Lida N, Saito K, Fukushima K. A case of extramedullary plasmacytoma arising from the lacrimal gland: a case report. Eur J Plast Surg. 2005;28:364-367.
(7.) Lazaridou MN, Micallef-Eynaud P, Hanna IT. Soft tissue plasmacytoma of the orbit as part of the spectrum of multiple myeloma. Orbit. 2007;26:315-318.
(8.) Movsas TZ, Balcer LJ, Eggenberger ER, Hess JL, Galetta SL. Sixth nerve palsy as a presenting sign of intracranial plasmacytoma and multiple myeloma. J Neuro-Opthalmol. 2000;20:242-245.
(9.) Johansen S, Heegard S, Bogeskov L, Prause JU. Orbital space occupying lesions in Denmark 1974-1997. Acta Opththalmol Scand. 2000;78:547-552.
(10.) Gunalp I, Gunduz K. Metastatic orbital tumors. Jpn J Opthalmol. 1995;39:65-70.
(11.) Jakobiec FA, Bilyk JR, Font RL. Orbit. In: Ophthalmic Pathology. Spencer WH Ed. Vol IV, 4 Ed, USA: WB Saunders. 1196;2438-934.
(12.) Hu K, Yahalom J. Radiotherapy in the management of plasma cell tumors. Oncology (Williston Park). 2000;14:101-108.
(13.) Yaneva MP, Goranova-Marinova V Goranov S. Palliative radiotherapy in patients with multiple myeloma. J Buon. 2004;124:485-487.
Mustafa Vatansever *, Fatma Merve Bozkurt *, Erdem Dinc *, Eda Bengi Yilmaz **, Erdinc Nayir ***, Ayse Ayca Sari *, Ozlem Yildirim *, Tuba Kara ****
* Mersin University Faculty of Medicine, Department of Ophthalmology, Mersin, Turkey
** Mersin University Faculty of Medicine, Department of Radiation Oncology, Mersin, Turkey
*** Mersin University Faculty of Medicine, Department of Oncology, Mersin, Turkey
**** Mersin University Faculty of Medicine, Department of Pathology, Mersin, Turkey
Address for Correspondence: Mustafa Vatansever MD, Mersin University Faculty of Medicine, Department of Ophthalmology, Mersin, Turkey Phone: +90 507 340 89 58 E-mail: firstname.lastname@example.org Received: 16.06.2014 Accepted: 19.09.2014 This article is also published in Turkish under doi:10.4274/tjo.73645 pages 2016;46:148-150.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestric distribution, and reproduction in any medium, provided the original work is properly cited.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Case Report|
|Author:||Vatansever, Mustafa; Bozkurt, Fatma Merve; Dinc, Erdem; Yilmaz, Eda Bengi; Nayir, Erdinc; Sari, Ayse|
|Publication:||Turkish Journal of Ophthalmology|
|Article Type:||Case study|
|Date:||May 1, 2016|
|Previous Article:||Objective determination of retinal function in Bietti crystalline retinopathy.|